<qa>  What is the name of the program that is designed to study the efficacy, safety,This program is designed to study the efficacy, safety, lipid effects and tolerability of raltegravir compared to lopinavirritonavir, in patients with HIV-I infection who have not received prior antiretroviral therapy. All patients will receive concomitant therapy with Truvada. 